In 2023, it is planned to allocate almost 310 billion rubles from the budget for the national Healthcare project. More
According to the DSM Group agency, as of January 20222009, the share of domestic drugs in the Russian market was 64%, but by October Rosstat recorded its growth by 29%. The situation is worse with medical products. According to Stanislav Goldberg, head of the commission for the circulation of medical devices in the public council of Roszdravnadzor, now up to 85% of this market is occupied by direct imports. Back in the spring, the main suppliers were the United States and European countries, but in recent months, logistics flows have increasingly switched to other countries.
The second half of last year confirmedhuge demand for advanced healthcare technologies in Russia. Of the major investment transactions in this area, one can note 1 billion rubles, attracted in October by the BestDoctor corporate medical insurance service. In addition, the Yakut company Saiberia, which is engaged in the creation of Russian medical software, received 173 million rubles for development. The developer of software (software) for the detection of oncological diseases, the Unim company, was completely bought out by the Tashir MEDICA investment holding in August. According to experts, the deal amounted to at least 100 million rubles.
According to Statista, in 2023 the market sizeMedTech in Russia will reach $4.75 billion. At the same time, the bulk of it will fall on medical devices and laboratory diagnostic technologies (in vitro). It is in these sectors that the most noticeable development dynamics are now observed and, accordingly, many medical startups are concentrated.
Advanced genetics in Russia
Since the spring of 2022, Russia has stoppedprovide services to many foreign companies engaged in the field of genetic diagnostics. This is a sought-after niche, since DNA analysis allows you to establish a patient's predisposition to certain hereditary diseases, plan a healthy pregnancy, and much more. However, there are also Russian organizations that are ready to provide a comparable, and even higher level of services.
One of them is Genotek, which not onlydraws conclusions based on genetic analysis for its clients, but also conducts research in the interests of many specialized domestic research institutes.
Among the recent results of scientific activityGenotek can be noted for its new algorithms for determining whether a person belongs to one of 586 “starting” populations. Thanks to this, it became possible to determine what nationality the previous generations were and, as a result, to identify diseases, predisposition to them, human nutritional characteristics, and so on. This required two years of research and analysis of more than 100 thousand genomes of Russian residents. Genotek services are available to residents of 16 countries, including Brazil, Mexico, Iran and others.
The company is moving in the same direction.Genetico, which is part of the biotechnology holding "Human Stem Cell Institute". She deals with issues of reproductive genetics, oncogenetics (screening and selection of personalized tumor therapy), as well as setting the nucleotide sequence in the DNA molecule using the latest generation technologies, which provides the most complete information about changes, both already identified and not seen before, helping to determine the genetic disease.
Import substitution of medical devices
In addition to the distribution of diagnostic tools invitro, we can note successes in the field of import substitution of highly sought-after medical products. The Russian brand and company “Hirana+” operate in this market segment. It began its activities as a supplier of Slovak ventilators, but in recent years it has taken the path of localizing the production of these devices and has already achieved that 70–80% of the components of ventilators are manufactured in Russia.
The company is now seeking to reduce its shareforeign components up to 10%, and over the next two to three years, completely abandon from them. In addition, literally over the last year she managed to develop her own turbine ventilator, which is not inferior to the world’s best expert-class models. This production has already been completely localized, testing of finished devices is planned for the spring of 2023.
The state will help
Today Russian MedTech exists and activelydevelops. Partial release of the market from competitors, interest from Russian investors, as well as active measures of state support within the framework of national projects and acceleration programs helped it to survive difficult times and get a new impetus for growth.
Genetico, Genotek and Hirana+ are united bynot only a common desire to increase the introduction of high medical technologies into the Russian healthcare system, but also the fact that they are all members of the Moscow Innovation Cluster (MIK). This organization, created by the Moscow government, is designed to help promising companies in introducing innovations and developing cooperation with large corporations, as well as educational and scientific organizations.
There is every reason to hope that in the futureThe domestic MedTech market will only expand, providing the industry with advanced development. The authorities will also assist him in this. In December 2022, the Ministry of Industry and Trade determined the priorities of state support in import substitution. Projects in six main areas will be able to apply for a higher volume of assistance, one of which is healthcare.
Read more:
Scientists first saw how a star devours the planet: this, in the end, is waiting for the Earth
Two super-Earths found on the edge of the habitable zone: one of them has a comfortable temperature
Modern humans migrated to Europe differently than previously thought
</ p>Cover photo: Image by DCStudio on Freepik